Anna Sundlöv

Doctoral Student, PhD student, MD

Research areas and keywords

UKÄ subject classification

  • Cancer and Oncology

Research

As a senior consultant of oncology specialized in endcrine tumors and radionuclide therapy, my research focuses on optimizing peptide receptor radionuclide therapy for patients with neuroendocrine tumors. The research is conducted in close collaboration with the department of medical radiation physics.

Recent research outputs

Bone marrow absorbed doses and correlations with hematological response during 177Lu-DOTATATE treatments are influenced by image-based dosimetry method and presence of skeletal metastases
Hagmarker, L., Svensson, J., Ryden, T., van Essen, M., Anna Sundlöv, Katarina Sjögreen Gleisner, Gjertsson, P. & Bernhardt, P., 2019 Mar 22, In : Journal of Nuclear Medicine.

Research output: Contribution to journal › Article

A prospective observational study to evaluate the effects of long-acting somatostatin analogs on 68Ga-DOTATATE uptake in patients with neuroendocrine tumors
Anni Gålne, Almquist, H., Martin Almquist, Hindorf, C., Ohlsson, T., Nordenström, E., Anna Sundlöv & Elin Trägårdh, 2019, In : Journal of Nuclear Medicine.

Research output: Contribution to journal › Article

The Effect of Radioiodine Treatment on TRAb, Anti-TPO, and Anti-TG in Graves' Disease
Ola Lindgren, Asp, P., Anna Sundlöv, Jan Tennvall, Bushra Shahida, Tereza Planck, Peter Åsman & Mikael Lantz, 2019, In : European Thyroid Journal. 8, 2, p. 64-69

Research output: Contribution to journal › Article

View All (16)

Anna Sundlöv

Doctoral Student, PhD student, MD

Affiliations

ORCID

ORCID: 0000-0003-1565-3496
Additional contact details